Theranostics News and Research

RSS

Total body PET/CT scans can effectively visualize systemic joint involvement in patients with arthritis

Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of The Journal of Nuclear Medicine.

14 Oct 2022

uPAR may be a promising target for therapy in patients with neuroendocrine neoplasms

A novel PET radiotracer can accurately assess the presence of a biomarker that indicates the level of tumor aggressiveness in neuroendocrine neoplasms (NENs).

28 Sep 2022

Gene therapy approach delays disease onset in humanized mouse models of familial ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive loss of motor neurons in the brain and spinal cord responsible for voluntary movements and muscle control.

2 Aug 2022

The Journal of Nuclear Medicine provides first-hand account of practicing medicine in wartime Ukraine

The Journal of Nuclear Medicine has published a first-hand account of the daily practice of nuclear medicine and molecular imaging during the ongoing war in Ukraine.

1 Aug 2022

New technique offers higher-precision scRNA-seq data than current technologies

The advent of single-cell RNA sequencing (scRNA-seq) has revolutionized the fields of medicine and biology by providing the ability to study the inner workings of thousands of cells at one go.

28 Jun 2022

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

7 Jun 2022

New deep learning method aids in the accurate diagnosis of parkinsonian diseases

A new deep learning method has been created to aid in the diagnosis of parkinsonian diseases, according to research published ahead of print by The Journal of Nuclear Medicine.

21 Apr 2022

Novel radioligand therapy shown to increase survival of metastatic prostate cancer patients

A novel prostate cancer treatment-;225Ac-PSMA-617 radioligand therapy-;has been shown to increase the progression free survival (PFS) and overall survival (OS) of metastatic castration-resistant prostate cancer (mCRPC) patients, according to research published by The Journal of Nuclear Medicine.

9 Mar 2022

New appropriate use criteria for prostate-specific membrane antigen PET imaging published

The Society of Nuclear Medicine and Molecular Imaging and peer medical groups have issued appropriate use criteria (AUC) for prostate-specific membrane antigen (PSMA) PET imaging.

7 Jan 2022

Smart transformable nanoparticles show promise for enhanced tumor theranostics

For more than three decades, biomedical nanomaterials have been successfully developed for the benefit of theranostics -- a compound term referring to the diagnoses and treatment of tumors.

7 Dec 2021

Study proves safety and effectiveness of novel radionuclide therapy for neuroendocrine neoplasms

A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission in some patients.

23 Nov 2021

Clinical dilemmas in breast cancer patients solved by newly approved PET imaging agent

A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for breast cancer patients when diagnostic dilemmas arise.

29 Sep 2021

NCI recognizes UC Davis as one of the most elite cancer centers

The National Cancer Institute once again recognized UC Davis Comprehensive Cancer Center as one of the nation's most elite cancer centers, awarding the center $17.5 million over five years and renewing the cancer center's "comprehensive" designation.

24 Sep 2021

New imaging technology for detecting MALT lymphomas could save patients numerous gastroscopies

A new imaging technique for the detection of MALT lymphomas, malignant tumours of the lymphatic system, could probably save patients numerous gastroscopies. A study group of MedUni Wien achieved a high imaging accuracy by way of PET/MR and by using a PET Tracer directed against a certain cell receptor. The results are currently published in the top journal "Blood" of the American Society of Hematology.

24 Sep 2021

New imaging technique can change the landscape of prostate cancer detection and treatment

Prostate-specific membrane antigen, or PSMA, -targeted PET imaging for prostate cancer has been a breakthrough diagnosis tool in locating prostate cancer tumors for more precise treatment.

16 Sep 2021

MGH researchers discover how triple-negative breast cancer can evade powerful drugs

Massachusetts General Hospital researchers have identified for the first time how a highly aggressive form of breast cancer can evade one of the most powerful and effective drugs used to treat it, reporting their findings in Cancer Discovery, a journal of the American Association for Cancer Research.

17 Aug 2021

Theranostics News and Research

Total body PET/CT scans can effectively visualize systemic joint involvement in patients with arthritis

uPAR may be a promising target for therapy in patients with neuroendocrine neoplasms

Gene therapy approach delays disease onset in humanized mouse models of familial ALS

The Journal of Nuclear Medicine provides first-hand account of practicing medicine in wartime Ukraine

New technique offers higher-precision scRNA-seq data than current technologies

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

New deep learning method aids in the accurate diagnosis of parkinsonian diseases

Novel radioligand therapy shown to increase survival of metastatic prostate cancer patients

New appropriate use criteria for prostate-specific membrane antigen PET imaging published

Smart transformable nanoparticles show promise for enhanced tumor theranostics

Study proves safety and effectiveness of novel radionuclide therapy for neuroendocrine neoplasms

Clinical dilemmas in breast cancer patients solved by newly approved PET imaging agent

NCI recognizes UC Davis as one of the most elite cancer centers

New imaging technology for detecting MALT lymphomas could save patients numerous gastroscopies

New imaging technique can change the landscape of prostate cancer detection and treatment

MGH researchers discover how triple-negative breast cancer can evade powerful drugs

New radiotracer opens the door for advancement of iron-targeted cancer therapies

Detailed performance evaluation of the uEXPLORER total-body PET/CT scanner

Molecular imaging can improve therapeutic management of pancreatic ductal adenocarcinomas

An affordable, scalable and highly sensitive virus-genome-based testing approach

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News